BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, June 5, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 24, 2017
View Archived Issues
Rigel synthesizes fused imidazole and pyrazole derivatives as TGF-beta inhibitors
Read More
BeiGene initiates pivotal trial of BGB-A317 in China for classical Hodgkin's lymphoma
Read More
ReViral reports topline phase I data on RV-521 for RSV
Read More
Starpharma achieves preclinical milestone under AstraZeneca license agreement
Read More
FDA approves infliximab biosimilar Renflexis
Read More
Preliminary phase III data for sublingual treatment for Parkinson's disease 'off' episodes
Read More
Novartis presents phase IIa data for BPS-804
Read More
Roche studies RO-7020531 in phase I for chronic hepatitis B
Read More
EMA committee recommends approval of inotuzumab ozogamicin
Read More
PreveCeutical Medical and UniQuest sign research and option agreement
Read More
Atara and Merck & Co. in clinical trial collaboration to evaluate ATA-129 with pembrolizumab
Read More
Spinraza recommended for approval in E.U.
Read More
Phase III data presented for Hizentra for the treatment of myasthenia gravis
Read More
AbbVie conducting second phase III study of ABT-494 in psoriatic arthritis
Read More
EMA's CHMP recommends approval of Brineura for CLN2 disease
Read More
Wockhardt patents novel antibacterials
Read More
Sandoz rituximab and etanercept biosimilars recommended for approval in E.U.
Read More
EMA committee recommends E.U. approval of Kevzara
Read More
EMA committee adopts positive opinion on Opdivo in locally advanced or metastatic urothelial cancer
Read More
Reprogramming mouse astrocytes rescues aspects of motor behavior in a model of Parkinson's disease
Read More
Model of obesity and chronic liver disease allows study of effects on hepatic encephalopathy
Read More
FDA allows trials of inhaled BIO-11006 in adults with lung cancer
Read More
Janssen Holding publishes provisional notice of end result of Actelion tender offer
Read More
ND0612, a new formulation for subcutaneous infusion of levodopa/carbidopa in advanced PD
Read More
Tiziana obtains approval in Israel of phase II trial protocol for milciclib in refractory HCC
Read More
